All News for Natera, Inc.
Date Title Preview Links
09/13/18 Bristol-Myers Squibb to Use Natera's Cell-Free DNA Assay in Immunotherapy Study

Bristol-Myers Squibb plans to use Natera's circulating...

VIEW ARTICLE
05/09/18 Natera to Seek FDA Clearance of Oncology Assay as NIPT Business Continues to Grow

Natera said it is on track for an end of the year or...

VIEW ARTICLE
04/20/18 Anticipating Clinical Launch, Natera Shares New Data on ctDNA Cancer Monitoring Tech

Natera shared new data this week on its recently-...

VIEW ARTICLE
04/11/18 11 innovations changing the world today

Is the patient responding to treatment? Is the patient...

VIEW ARTICLE
08/14/17 A blood test for cancer could be closer than people realize

Natera has developed a blood test that can detect cancer...

VIEW ARTICLE
07/25/17 A simple new blood test that can catch cancer early

Jimmy Lin is developing technologies to catch cancer...

VIEW ARTICLE
05/09/17 Q&A with Matthew Rabinowitz, PhD: detecting relapse by liquid biopsy

Bespoke polymerase chain reaction (PCR) is an emerging...

VIEW ARTICLE
04/26/17 Liquid-biopsies success highlights power of combining basic and clinical research

One of the biggest obstacles to surviving cancer is the...

VIEW ARTICLE
04/21/17 Early TRACERx Results Illuminate Tumor Evolution, Show Promise of Natera cfDNA Analyses.

NEW YORK (GenomeWeb) – Researchers this week shared...

View Article
04/21/16 5 Reasons to Consider Genetic Testing Before You Get Pregnant

Deciding whether to have a baby is one of the biggest...

View Article
04/16/16 ​Inc.’s 2016 list of newly public companies driving innovation. View Profile
08/17/15 5 Common Misconceptions about PGS and PDG You Need to Know

Your doctors tell you one thing, your family and friends...

View Article
Back to Top